{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Kalaris Therapeutics, Inc. "},"Symbol":{"label":"Symbol","value":"KLRS"},"Address":{"label":"Address","value":"1100 WINTER STREET,SUITE 500, WALTHAM, Massachusetts, 02451, United States"},"Phone":{"label":"Phone","value":"+1 212 915 2577"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Kalaris was founded by experienced leaders in ophthalmology drug development and commercialization to address a major unmet need in the treatment of retinal diseases.Existing therapies for retinal neovascular / exudative diseases have made great strides in preserving or improving vision, but they require frequent clinic visits over many years that place a significant burden on patients and caregivers. This onerous visit regimen often leads to missed or delayed injections and suboptimal patient outcomes."},"CompanyUrl":{"label":"Company Url","value":"https://www.kalaristx.com"}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}